United States · Series B startup

Who invested in Curology

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2016, from 1 source

Latest round
Series B, $15MAug 2016
Investors
1
See who backed them

The rounds

  1. Aug 2016
    Series B$15M

    Reported by FinSMEsSEC filing: $15M sold, first sale Apr 2016

Founders and team

From the SEC filings it signed: 2 on the team.

  • David LortscherExecutive Officer, Directori
  • Glenn LortscherExecutive Officeri

On the board, as filediCourtney RobinsonKris FredricksonScott Stanford

Everyone who backed them

Advance Vixeid PartnersGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Curology as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Forerunner VenturesVC firmPer its own site
Advance Venture PartnersPrivate equityPer its own site
AnfaPrivate equityPer its own site

Quick answers about Curology

Who invested in Curology?

Curology's investors include Advance Vixeid Partners.

How much has Curology raised?

Curology has raised $15M across 1 round since 2016.

When did Curology last raise?

Curology's most recent round was a Series B of $15M in Aug 2016.

What was Curology's biggest round?

Its most recent round, $15M in Aug 2016, is also its largest on record.

Who backed Curology first?

Curology's first round on record, in Aug 2016, was backed by Advance Vixeid Partners.

What stage is Curology at?

Curology's latest named round is a Series B, in Aug 2016.

Where is Curology based?

Curology is based in the United States.

Companies like Curology

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.